Research shows tumor debulking in advanced colorectal cancer does not enhance survival outcomes and may increase adverse ...

Patients with prior malignancy showed improved cancer-specific survival in metastatic colorectal cancer (mCRC), but prior skin tumors or malignancies diagnosed over five years earlier worsened ...

Bria-IMT combined with a checkpoint inhibitor improved overall survival in metastatic breast cancer compared to Trodelvy and chemotherapy. In triple-negative breast cancer, Bria-IMT showed a median ...

Eraglusib combined with gemcitabine and nab-paclitaxel significantly improved overall survival in metastatic pancreatic ductal adenocarcinoma patients. The combination therapy showed a favorable ...

Spinal metastasis, the spread of cancer to the spine, is a frequent complication in advanced cancer. It often causes severe pain and paralysis, significantly impacting quality of life. Surgery may be ...

Adding the investigational drug elraglusib to standard first-line gemcitabine and nab-paclitaxel (GnP) may extend the lives of some patients with metastatic pancreatic ductal adenocarcinoma (PDAC), ...